CHMMF vs AMGN: Which Stock is Better?
Side-by-side comparison of Chimeric Therapeutics Limited and Amgen Inc in 2026
CHMMF
Chimeric Therapeutics Limited
$0.00
AMGN
Amgen Inc
$355.30
Key Metrics Comparison
| Metric | CHMMF | AMGN | Winner |
|---|---|---|---|
| Market Cap | $4.42M | $191.53B | AMGN |
| P/E Ratio | N/A | 24.57 | AMGN |
| EPS (TTM) | $N/A | $14.46 | AMGN |
| Revenue Growth | -0.5% | 0.1% | AMGN |
| Gross Margin | 91.3% | 70.8% | CHMMF |
Analyze CHMMF
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CHMMF or AMGN a better investment?
Comparing CHMMF and AMGN: Chimeric Therapeutics Limited has a market cap of $4.42M while Amgen Inc has $191.53B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CHMMF and AMGN?
CHMMF (Chimeric Therapeutics Limited) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CHMMF or AMGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CHMMF or AMGN?
AMGN has higher revenue growth at 0.1% vs -0.5% for CHMMF.
Which company is more profitable: CHMMF or AMGN?
Chimeric Therapeutics Limited (CHMMF) has higher gross margins at 91.3% compared to 70.8% for AMGN.
Which is the larger company: CHMMF or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $191.53B compared to $4.42M for CHMMF.
Should I buy CHMMF or AMGN in 2026?
Both CHMMF and AMGN have investment merit. CHMMF trades at $0.00 while AMGN trades at $355.30. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CHMMF and AMGN stock?
Key differences: Market Cap ($4.42M vs $191.53B), P/E Ratio (N/A vs 24.6x), Revenue Growth (-0.5% vs 0.1%), Gross Margin (91.3% vs 70.8%).